Zimmer Biomet Holdings (ZBH) Cash from Investing Activities (2009 - 2026)

Zimmer Biomet Holdings' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$159.0 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 50.0% year-over-year to -$159.0 million in Q1 2026; TTM through Mar 2026 was -$2.0 billion, a 153.87% decrease from a year earlier, with the FY2025 full-year figure at -$2.0 billion, down 122.46% from the prior year.
• Cash from Investing Activities improved to -$159.0 million in Q1 2026 per ZBH's latest filing, from -$322.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$81.1 million in Q1 2022 and bottomed at -$1.4 billion in Q2 2025.
• The 5-year median for Cash from Investing Activities is -$165.6 million (2023), against an average of -$254.3 million.
• Biggest YoY gain for Cash from Investing Activities was 45.64% in 2025; the steepest drop was 460.49% in 2025.
• Year by year, Cash from Investing Activities stood at -$112.5 million in 2022, then slumped by 96.27% to -$220.8 million in 2023, then slumped by 31.88% to -$291.2 million in 2024, then retreated by 10.58% to -$322.0 million in 2025, then jumped by 50.62% to -$159.0 million in 2026.
• Per Business Quant, the three latest ZBH Cash from Investing Activities figures stand at -$159.0 million (Q1 2026), -$322.0 million (Q4 2025), and -$163.3 million (Q3 2025).